Becton Dickinson - 41 Year Stock Price History | BDX

Historical daily share price chart and data for Becton Dickinson since 1983 adjusted for splits and dividends. The latest closing stock price for Becton Dickinson as of November 19, 2024 is 222.64.
  • The all-time high Becton Dickinson stock closing price was 278.14 on July 27, 2023.
  • The Becton Dickinson 52-week high stock price is 249.89, which is 12.2% above the current share price.
  • The Becton Dickinson 52-week low stock price is 218.75, which is 1.7% below the current share price.
  • The average Becton Dickinson stock price for the last 52 weeks is 236.54.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Becton Dickinson Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 234.9603 242.5058 245.4893 220.5866 222.6400 -7.59%
2023 248.7436 249.3661 278.1395 224.4764 240.9347 -2.67%
2022 240.4800 237.1093 265.3193 211.7070 247.5361 5.12%
2021 230.7328 231.5946 245.2938 220.0534 235.4893 1.88%
2020 227.1043 248.4116 260.6708 183.4482 231.1512 -6.75%
2019 223.9521 198.1332 249.2775 190.1387 247.8920 22.20%
2018 210.8245 193.6188 237.2363 187.8121 202.8506 6.62%
2017 171.8836 144.6265 202.1398 144.3200 190.2591 31.23%
2016 142.2486 127.4401 158.2838 114.4592 144.9768 9.23%
2015 122.8277 118.4264 134.8307 111.8459 132.7290 12.64%
2014 100.0621 90.7419 119.1006 87.6324 117.8337 28.27%
2013 80.6347 64.7029 91.9558 64.7029 91.8644 44.27%
2012 61.3511 59.1707 64.4423 57.7087 63.6768 7.23%
2011 62.9650 65.9267 70.5217 55.8991 59.3852 -9.70%
2010 57.8196 59.9226 66.3858 51.5109 65.7633 9.39%
2009 52.2001 52.2332 60.7765 45.4526 60.1209 17.57%
2008 60.1502 63.9056 68.0000 44.8217 51.1341 -16.92%
2007 57.0880 51.1879 62.6041 50.7663 61.5491 20.72%
2006 47.3218 43.3467 53.4502 42.1052 50.9844 18.34%
2005 39.8549 39.6338 43.5403 35.7712 43.0813 7.19%
2004 35.1076 28.6859 40.9217 28.6859 40.1928 39.74%
2003 25.2236 21.7890 28.9795 20.3451 28.7628 35.66%
2002 22.6148 22.7285 26.3346 17.1658 21.2018 -6.32%
2001 23.5088 23.0862 26.3341 20.4067 22.6329 -3.21%
2000 19.1315 17.4660 23.7210 15.0689 23.3834 30.15%
1999 21.2363 28.3653 28.3653 16.1722 17.9662 -36.20%
1998 24.6686 16.3556 30.8609 16.1921 28.1608 72.18%
1997 15.9429 14.0403 17.9766 14.0403 16.3556 16.49%
1996 13.2821 12.1215 14.3994 11.5037 14.0403 16.99%
1995 9.3822 7.6136 12.0843 7.6136 12.0014 58.45%
1994 6.5063 5.5587 7.8314 5.3062 7.5741 36.75%
1993 5.6386 5.9108 6.1199 5.0028 5.5385 -7.34%
1992 5.5515 4.9639 6.3517 4.9168 5.9770 16.68%
1991 5.2347 5.4958 5.9508 4.3439 5.1224 -6.48%
1990 4.7991 4.5289 5.5877 4.0588 5.4774 22.39%
1989 3.9686 3.6406 4.4754 3.4794 4.4754 21.16%
1988 3.8120 3.5995 4.3219 3.2965 3.6939 3.63%
1987 4.0495 3.5208 4.7644 3.0777 3.5645 2.50%
1986 3.3128 2.1694 4.2344 2.1694 3.4777 61.29%
1985 1.8269 1.3824 2.2647 1.3824 2.1562 56.48%
1984 1.2542 1.3128 1.4172 1.0739 1.3779 7.82%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $64.352B $20.178B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Cardinal Health (CAH) United States $28.637B 15.53
West Pharmaceutical Services (WST) United States $22.024B 44.99
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36